Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Clinical Documents
2001 ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation
The goal of this document is to provide guidance for better management of this frequent and complex arrhythmia.
October 1, 2001
Clinical Documents
2001 The Role(s) of the Industry-Employed Allied Professional
The Ad Hoc NASPE/Industry Task Force developed this policy statement to clarify the role industry-employed allied professionals (IEAPs) should play in the clinical environment, with…
March 1, 2001
2000 Practical Guidelines for Clinicians Who Treat Patients with Amiodarone
June 26, 2000 — These guidelines present an approach to the use…
June 26, 2000
Clinical Trials
The MUSTT Trial
Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.
December 16, 1999
Clinical Trials
The MADIT Trial
In patients with a prior MI who are at high risk for VT, prophylactic therapy with an implanted defibrillator leads to improved survival as compared…
December 26, 1996
Clinical Documents
1996 AHA/NASPE Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations
The American Heart Association and the North American Society of Pacing and Electrophysiology (NASPE) cosponsored two conferences on medical and regulatory issues related to arrhythmias…
September 1, 1996
Clinical Trials
The CAST Trial
Antiarrhythmic drugs flecainide and encainide may actually increase mortality in post-MI patients with asymptomatic ventricular arrhythmias.
March 21, 1991
- « Previous
- 1
- …
- 53
- 54
- 55